Introducción: Stem Cells in Spinal Disc Repair Spinal disc herniations are a common spinal disorder that can cause significant pain and disability. Traditional treatments for disc herniations, such as surgery and physical therapy, have limited efficacy and can be associated with significant complications. Stem cell therapy has emerged as a promising new treatment option for disc herniations, offering the potential for tissue regeneration and pain relief.

Pathophysiology of Spinal Disc Herniations

Spinal discs are located between the vertebrae and act as shock absorbers. They consist of a tough outer layer (annulus fibrosus) and a soft, gelatinous center (nucleus pulposus). Disc herniation occurs when the nucleus pulposus pushes through the annulus fibrosus, causing compression of the spinal cord or nerve roots. This compression can lead to pain, entumecimiento, weakness, and other symptoms.

Role of Stem Cells in Tissue Regeneration

Stem cells are unspecialized cells that have the ability to differentiate into a variety of cell types. This makes them ideal for use in tissue regeneration, as they can be transplanted into damaged tissue and differentiate into the specific cell types needed for repair. In the case of disc herniations, stem cells can differentiate into annulus fibrosus and nucleus pulposus cells, helping to restore the structural integrity of the disc.

Preclinical Studies on Stem Cell Therapy for Disc Herniations

Los estudios preclínicos en modelos animales han demostrado el potencial de terapia con células madre for disc herniations. In these studies, stem cells have been shown to promote disc regeneration, reducir el dolor, and improve neurological function. These findings have paved the way for clinical trials to evaluate the safety and efficacy of terapia con células madre in humans.

Clinical Trials Utilizing Stem Cells for Disc Repair

Several clinical trials have been conducted to evaluate the use of stem cells for disc herniation repair. These trials have shown promising results, with some patients experiencing significant pain relief and improved function. Sin embargo, further research is needed to determine the optimal stem cell source, dosificación, and delivery method for this therapy.

Categorías: Bronquitis crónica Ataque Ataque de isquemia transitoriaconferencias de anestesiologíamedicamento antirradiaciónGastritis atróficaTiroiditis autoinmunecardiologíaconferencia de cardiología 2018Insuficiencia cardíaca crónica Insuficiencia renal crónicaensayos clínicosTerapia con células madre de cuperosis rosáceacursocertificación craconferencia medicatransferencia de embriones congeladosconferencias de geriatríatiroides de HashimotoneurologíaoncologíaDolorconferencias sobre el dolorDieta para la pancreatitisTrastorno de pánicoenfermedad de parkinsonRiesgos potenciales de las terapias con células madreTratamiento con células madreCélulas madre en EuropaMercado de células madreTerapia con células madreTratamiento con células madrecélulas madreEnsayos clínicos de células madreTerapia con células madreterapia con células madreTerapia con células madre de la parálisis cerebraltratamiento con células madreadvertencia de células madre

NB Ciencia

organización de investigación por contrato